Alembic Pharmaceuticals Community

NSEI:APLLTD Community

1 Narratives written by author
0 Comments on narratives written by author
5 Fair Values set on narratives written by author

Alembic Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 11 Analysts

Future US Launches And GLP-1 Investments Will Strengthen Market Position

Key Takeaways Aggressive U.S. product launch strategy and peptide investments to counter price erosion and drive future high-margin revenue growth. Focus on domestic market optimization and strategic R&D expense reduction to improve net margins and earnings.

₹1.05k

FV

19.4% undervalued

11.23%

Revenue growth p.a.

0

0

2

Updated